Health ❯ Healthcare ❯ Clinical Trials ❯ Cancer Treatment

Breast Cancer

Kisqali Cuts Recurrence in 5-Year NATALEE Results for High-Risk Early HR+/HER2- Breast Cancer

Follow-up continues to confirm overall survival after a three-year course showed durable benefit.

Remote Coaching Program Drives One-Year Weight Loss in Large Breast Cancer Trial